Effects of sacubitril-valsartan alone or in combination with dapagliflozin on aging-related heart failure with preserved ejection fraction

Back

HFA Premium Access

Effects of sacubitril-valsartan alone or in combination with dapagliflozin on aging-related heart failure with preserved ejection fraction

Session: ePosters in chronic heart failure - pathophysiology and mechanisms (2)

Topic: Experimental Heart Failure

Speaker: Doctor E. Mele (Naples, IT)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Doctor Elena Mele

Naples (Italy)

0 follower

7 more presentations in this session

Multimodal predictive model for 6-month treatment-related cardiotoxicity in non-Hodgkin lymphoma patients

Speaker: Doctor D. Bursacovschi (Chisinau, MD)

Deciphering doxorubicin-induced cardiotoxicity:insights at single-cell resolution

Speaker: Mr J. Van Fraeyenhove (Turin, IT)

Takotsubo syndrome stress induced heart failure syndrome with significant LVOT obstruction

Speaker: Doctor D. Kutlesic Kurtovic (Nis, RS)

Nicotinamide-N-methyltransferase inhibition improves cardiac function and structure in a heart failure with preserved ejection fraction mouse model

Speaker: Mr S. Li (Groningen, NL)

Evaluation of the predictive value of the HFA-ICOS score for cardiotoxicity in breast cancer patients treated with anthracyclines and trastuzumab: a real-world observational study

Speaker: Doctor D. Faro (Catania, IT)

Access the full session

ePosters in chronic heart failure - pathophysiology and mechanisms (2)

Speakers: Doctor E. Mele, Doctor D. Bursacovschi, Mr J. Van Fraeyenhove, Doctor D. Kutlesic Kurtovic, Mr S. Li...

Access

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources